ICLR

ICLR

USD

ICON plc Ordinary Shares

$146.690+2.270 (1.572%)

Reaalajas hind

Healthcare
Diagnostics & Research
Iirimaa

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$144.420

Kõrge

$148.310

Madal

$142.640

Maht

1.28M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

11.7B

Tööstusharu

Diagnostics & Research

Riik

Ireland

Kauplemisstatistika

Keskmine maht

1.49M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $125.1Praegune $146.690Kõrge $347.72

Seotud uudised

PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

Vaata rohkem
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

Vaata rohkem
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
BusinessWire

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

ICON plc, (NASDAQ:ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair 45th Annual Growth

Vaata rohkem
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

Vaata rohkem
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
BusinessWire

ICON releases its ICON Cares 2024 Report

ICON plc, (NASDAQ:ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how the company is delivering on its

Vaata rohkem
ICON releases its ICON Cares 2024 Report
PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

Analyst Upgrades

Mizuho Maintains Outperform on Icon, Lowers Price Target to $173

Mizuho analyst Ann Hynes maintains Icon with a Outperform and lowers the price target from $200 to $173.

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.